First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial
Ciaranello, Andrea L, Lockman, Shahin, Freedberg, Kenneth A, Hughes, Michael, Chu, Jennifer, Currier, Judith, Wood, Robin, Holmes, Charles B, Pillay, Sandy, Conradie, Francesca, McIntyre, James, LosinТом:
25
Мова:
english
Журнал:
AIDS
DOI:
10.1097/qad.0b013e3283428cbe
Date:
February, 2011
Файл:
PDF, 450 KB
english, 2011
File converter
Більше результатів пошуку
More benefits 
